Its possible that some of these peptides could have real benefits, but evidence for such benefits in people is largely absent
Biomolecules 10 , 1489(2020)
If urine copper exceeds this level, therapy should be paused
This article describes published research literature on two synthetic peptides for orientation within the UK research community
The safety profile of treatments for gout is generally quite good, despite the caveats mentioned above, for example, in the discussions of colchicine and allopurinol. For this reason, I believe that the great majority of gout sufferers would be well-served to explore traditional options for gout first and then choose their options
This indicates that all opioid ligands do not have the same potency to promote OR desensitization